Abstract
MicroRNAs (miRNAs) play an important role in physiological and pathological condition in human organs including kidneys. Their dysregulation on one hand can induce the onset of a specific disease and on the other hand may represent potential biomarkers for the diagnosis and therapy. In this chapter, the miRNA functions and modulations are described in several kidney diseases such as polycystic kidney disease, primary and secondary glomerulonephritides and renal transplantation. After the overview on the approach to identify and study miRNAs in nephrology, the miRNA meaning in renal physiology is illustrated. Also, the attractive perspectives of the use of miRNAs as diagnostic tools or for the specific treatment of kidney disease are taken into consideration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- AGO:
-
Argonaute
- AKI:
-
Acute kidney injury
- ANA:
-
Autoantibodies to nuclear antigen
- ASO:
-
Antisense oligonucleotide
- Bicc1:
-
Bicaudal C. homolog 1
- CAMR:
-
Chronic antibody mediated rejection
- Cdc25A:
-
Cell division cycle 25A
- cDNA:
-
Complementary DNA
- DGCR8:
-
RNA-binding protein DiGeorge syndrome critical region gene 8
- DGF:
-
Delayed graft function
- EMT:
-
Epithelial-to-mesenchymal transition
- FPC:
-
Fibrocystin
- GTP:
-
Guanosine triphosphate
- HBEGF:
-
Heparin binding epidermal growth factor
- HCV:
-
Hepatitis C virus
- HIVAN:
-
HIV associated nephropathy
- IF:
-
Interstitial fibrosis
- IFN:
-
Interferon
- IRAK1:
-
IL-1 receptor associated kinase1
- IRI:
-
Ischemia-reperfusion injury
- LN:
-
Lupus nephritis
- miRNA:
-
MicroRNA
- MRE:
-
MiRNA recognition elements
- OREB:
-
Osmotic response element binding protein
- PAZ:
-
Piwi-Argonaute-Zwille
- PBMCs:
-
Peripheral blood mononuclear cells
- PC:
-
Polycystin
- PKD:
-
Polycystic kidney disease
- pri-miRNA:
-
Primary miRNA transcript
- RISC:
-
RNA-induced silencing complex
- shRNA:
-
Small hairpin RNA
- SLE:
-
Systemic lupus erythematosus
- TA:
-
Tubular atrophy
- TAL:
-
Thick ascending limb
- TGF:
-
Transforming growth factor
- TNF:
-
Tumor necrosis factor
- TRAF6:
-
Tumor necrosis factor receptor-associated factor 6
- TRBP:
-
Transactivator RNA binding protein
- UTR:
-
Untranslated region
- VEGF:
-
Vascular endothelial growth factor
- VLP:
-
Virus like particles
- WMLK:
-
With-no-lysine kinase
References
Aguado-Fraile E, Ramos E, Conde E, et al. MicroRNAs in the kidney: novel biomarkers of acute kidney injury. Nefrologia. 2013;33:826–34.
Ambros V. The function of animal microRNAs. Nature. 2004;431:350–5.
Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A. 2009;106:5330–5.
Bao H, Chen H, Zhu X, et al. MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin α4 and α5 in IgA nephropathy. Kidney Int. 2014a;85:624–35.
Bao H, Hu S, Zhang C, et al. Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy. Biochem Biophys Res Commun. 2014b;444:455–60.
Ben-Dov IZ, Muthukumar T, Morozov P, et al. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation. 2012;94:1086–94.
Bijkerk R, van Solingen C, de Boer HC, et al. Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity. J Am Soc Nephrol. 2014;25:1710–22.
Brodersen P, Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol. 2009;10:141–8.
Cai X, Xia Z, Zhang C, et al. Serum microRNAs levels in primary focal segmental glomerulosclerosis. Pediatr Nephrol. 2013;28:1797–801.
Carlsen AL, Schetter AJ, Nielsen CT, et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 2013;65:1324–34.
Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997–1006.
Chen W, Lin X, Huang J, et al. Integrated profiling of microRNA expression in membranous nephropathy using high-throughput sequencing technology. Int J Mol Med. 2014;33:25–34.
Cheng K, Rai P, Plagov A, et al. MicroRNAs in HIV-associated nephropathy (HIVAN). Exp Mol Pathol. 2013a;94:65–72.
Cheng K, Rai P, Plagov A, et al. Rapamycin-induced modulation of miRNA expression is associated with amelioration of HIV-associated nephropathy (HIVAN). Exp Cell Res. 2013b;319:2073–80.
Dai Y, Huang YS, Tang M, et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus. 2007;16:939–46.
Dai Y, Sui W, Lan H, et al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int. 2009;29:749–54.
Danger R, Pallier A, Giral M, et al. Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. J Am Soc Nephrol. 2012;23:597–606.
Danger R, Paul C, Giral M, et al. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PLoS ONE. 2013;8:e60702.
Divekar AA, Dubey S, Gangalum PR, et al. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J Immunol. 2011;15:924–30.
Du R, Sun W, Xia L, et al. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS ONE. 2012;7:e30771.
Duan J, Huang H, Lv X, et al. PKHD1 post-transcriptionally modulated by miR-365-1 inhibits cell-cell adhesion. Cell Biochem Funct. 2012;30:382–9.
Dweep H, Sticht C, Kharkar A, et al. Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model. PLoS ONE. 2013;8:e53780.
Eltzschig HK, Eckle T. Ischemia and reperfusion – from mechanism to translation. Nat Med. 2011;17:1391–401.
Elvira-Matelot E, Zhou XO, Farman N, et al. Regulation of WNK1 expression by miR-192 and aldosterone. J Am Soc Nephrol. 2010;21:1724–31.
Flynt AS, Thatcher EJ, Burkewitz K, et al. miR-8 microRNAs regulate the response to osmotic stress in zebrafish embryos. J Cell Biol. 2009;185:115–27.
Gebeshuber CA, Kornauth C, Dong L, et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med. 2013;19:481–7.
Godwin JG, Ge X, Stephan K, et al. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A. 2010;107:14339–44.
Gong Y, Renigunta V, Himmerkus N, et al. Claudin-14 regulates renal Ca++ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J. 2012;31:1999–2012.
Gong Y, Himmerkus N, Plain A, et al. Epigenetic regulation of microRNAs controlling CLDN14 expression as a mechanism for renal calcium handling. J Am Soc Nephrol. 2014; pii: ASN.2014020129.
Harvey SJ, Jarad G, Cunningham J, et al. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol. 2008;19:2150–8.
Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol. 2008;19:2069–75.
Huang W, Liu H, Wang T, et al. Tonicity-responsive microRNAs contribute to the maximal induction of osmoregulatory transcription factor OREBP in response to high-NaCl hypertonicity. Nucleic Acids Res. 2011;39:475–85.
Jang HR, Ko GJ, Wasowska BA, et al. The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med. 2009;87:859–64.
Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013;368:1685–94.
Krebs CF, Kapffer S, Paust HJ, et al. MicroRNA-155 drives TH17 immune response and tissue injury in experimental crescentic GN. J Am Soc Nephrol. 2013;24:1955–65.
Lee SO, Masyuk T, Splinter P, et al. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest. 2008;118:3714–24.
Lin DH, Yue P, Pan C, et al. MicroRNA 802 stimulates ROMK channels by suppressing caveolin-1. J Am Soc Nephrol. 2011;22:1087–98.
Lin DH, Yue P, Zhang C, et al. MicroRNA-194 (miR-194) regulates ROMK channel activity by targeting intersectin 1. Am J Physiol Renal Physiol. 2014;306:F53–60.
Liu F, Lou YL, Wu J, et al. Upregulation of microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/perfusion injury in vivo and in vitro. Kidney Blood Press Res. 2012;35:182–91.
Lorenzen JM, Kielstein JT, Hafer C, et al. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2011a;6:1540–6.
Lorenzen JM, Volkmann I, Fiedler J, et al. Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant. 2011b;11:2221–7.
Lu J, Kwan BC, Lai FM, et al. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology. 2012;17:346–51.
Maluf DG, Dumur CI, Suh JL, et al. The urine microRNA profile may help monitor post-transplant renal graft function. Kidney Int. 2014;85:439–49.
Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513–8.
Mladinov D, Liu Y, Mattson DL, et al. MicroRNAs contribute to the maintenance of cell-type-specific physiological characteristics: miR-192 targets Na+/K+-ATPase β1. Nucleic Acids Res. 2013;41:1273–83.
Pan W, Zhu S, Yuan M, et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol. 2010;184:6733–81.
Pan Y, Jia T, Zhang Y, et al. MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice. Int J Nanomedicine. 2012;7:5957–67.
Pandey P, Brors B, Srivastava PK, et al. Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics. 2008;9:624.
Pandey P, Qin S, Ho J, et al. Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease. BMC Syst Biol. 2011;5:56.
Papagregoriou G, Erguler K, Dweep H, et al. A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy. PLoS ONE. 2012;7:e31021.
Patel V, Hajarnis S, Williams D, et al. MicroRNAs regulate renal tubule maturation through modulation of Pkd1. J Am Soc Nephrol. 2012;23:1941–18.
Patel V, Williams D, Hajarnis S, et al. miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease. Proc Natl Acad Sci U S A. 2013;110:10765–70.
Putta S, Lanting L, Sun G, et al. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol. 2012;23:458–69.
Qin W, Chung AC, Huang XR, et al. TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol. 2011;22:1462–74.
Saikumar J, Hoffmann D, Kim TM, et al. Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury. Toxicol Sci. 2012;129:256–67.
Scian MJ, Maluf DG, David KG, et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant. 2011;11:2110–22.
Sequeira-Lopez ML, Weatherford ET, Borges GR, et al. The microRNA-processing enzyme dicer maintains juxtaglomerular cells. J Am Soc Nephrol. 2010;21:460–7.
Serino G, Sallustio F, Cox SN, et al. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol. 2012;23:814–24.
Serino G, Sallustio F, Curci C, et al. Role of let-7b in the deregulation process of IgA1 glycosylation in IgA nephropathy. Nephrol Dial Transplant. 2015;30:1132–9.
Shapiro MD, Bagley J, Latz J, et al. MicroRNA expression data reveals a signature of kidney damage following ischemia reperfusion injury. PLoS One. 2011;6:e23011.
Shi S, Yu L, Chiu C, et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol. 2008;19:2159–69.
Spinetti G, Fortunato O, Caporali A, et al. MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ Res. 2013;112:335–46.
Stagakis E, Bertsias G, Verginis P, et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis. 2011;70:1496–506.
Sui W, Liu F, Chen J, et al. Microarray technology for analysis of microRNA expression in renal biopsies of lupus nephritis patients. Methods Mol Biol. 2014;1134:211–20.
Sun Y, Koo S, White N, et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 2004;32:e188.
Sun H, Li QW, Lv XY, et al. MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation. Mol Biol Rep. 2010;37:2951–8.
Te JL, Dozmorov IM, Guthridge JM, et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One. 2010;5:e10344.
Tian Z, Greene AS, Pietrusz JL, Matus IR, Liang M. MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res. 2008;18:404–11.
Tran U, Zakin L, Schweickert A, et al. The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity. Development. 2010;137:1107–16.
van Rooij E, Kauppinen S. Development of microRNA therapeutics is coming of age. EMBO Mol Med. 2014;6:851–64.
Wang G, Kwan BC, Lai FM, et al. Intrarenal expression of microRNAs in patients with IgA nephropathy. Lab Invest. 2010a;90:98–103.
Wang G, Tam LS, Li EK, et al. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol. 2010b;37:2516–22.
Wang G, Tam LS, Li EK, et al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus. 2010c;20:493–500.
Wang H, Peng W, Ouyang X, et al. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res. 2012;160:198–206.
Wang G, Kwan BC, Lai FM, et al. Urinary sediment miRNA levels in adult nephrotic syndrome. Clin Chim Acta. 2013;418:5–11.
Wei Q, Bhatt K, He HZ, Mi QS, Haase VH, Dong Z. Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol. 2010;21:756–61.
Wilflingseder J, Regele H, Perco P, et al. miRNA profiling discriminates types of rejection and injury in human renal allografts. Transplantation. 2013;95:835–41.
Wilflingseder J, Sunzenauer J, Toronyi E, et al. Molecular pathogenesis of post-transplant acute kidney injury: assessment of whole-genome mRNA and miRNA profiles. PLoS One. 2014;9:e104164.
Wu J, Zheng C, Fan Y, et al. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol. 2014;25:92–104.
Zarjou A, Yang S, Abraham E, Agarwal A, et al. Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol. 2011;301:F793–801.
Zhang W, Zhang C, Chen H, et al. Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS. Clin J Am Soc Nephrol. 2014;9:1545–52.
Zhao X, Tang Y, Qu B, et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthr Rheum. 2010;62:3425–35.
Zhao S, Wang Y, Liang Y, et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthr Rheum. 2011;63:1376–86.
Zhou H, Hasni SA, Perez P, et al. MiR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol. 2013;24:1073–87.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Serino, G., Sallustio, F., Schena, F.P. (2016). MicroRNAs in Kidney Diseases. In: Patel, V., Preedy, V. (eds) Biomarkers in Kidney Disease. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7699-9_40
Download citation
DOI: https://doi.org/10.1007/978-94-007-7699-9_40
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7698-2
Online ISBN: 978-94-007-7699-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences